1. "Meeting abstract"
  2. "Peter Scardino"
  3. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (22)
Groups
  1. Department of Medicine (22)
  2. Genitourinary Oncology Service (22)
  3. Molecular Pharmacology and Chemistry Program Faculty (22)
  4. Sloan Kettering Institute Faculty (22)
  5. Solid Tumor Oncology Division (22)
  6. Surgery (22)

More Groups

People
  1. Peter Scardino (22)
  2. Howard Scher (21)
  3. James Eastham (8)
  4. Victor Reuter (8)
  5. Fernando Bianco (7)
  6. Jaya Satagopan (6)

More People

Years
  1. 2021 (1)
  2. 2016 (1)
  3. 2015 (1)
  4. 2014 (1)
  5. 2012 (1)
  6. 2009 (2)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Modern Pathology (3)
  3. Cancer Research (2)
  4. Laboratory Investigation (2)
  5. Annals of Oncology (1)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (3)
  3. Nature Research (3)
  4. Nature Publishing Group (2)
  5. Oxford University Press (1)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing
    Meeting Abstract

    Truong, H.; Breen, K.; Kemel, Y.; Lenis, A. T.; Reisz, P.; Benfante, N.; Ehdaie, B.; Touijer, K. A.; Laudone, V. P.; Scardino, P. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy
    Meeting Abstract

    Miller, K.; Mulders, P.; Freedland, S. J.; Scher, H.; Shore, N.; Park, E.; Krivoshik, A.; Phung, D.; Modelska, K.; Scardino, P.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients
    Meeting Abstract

    O'Shaughnessy, M.; Eastham, J. A.; Bochner, B. H.; Laudone, V. P.; Carver, B. S.; Sjoberg, D.; Scardino, P. T.; Scher, H. I.; Touijer, K. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer
    Meeting Abstract

    Touijer, K. A.; Carver, B. S.; Coleman, J. A.; Laudone, V. P.; Hullings, M.; Ehrlich, S. S.; DeNunzio, M.; Reuter, V. E.; Eastham, J. A.; Danila, D. C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Does the catalytic activity of prostate-specific antigen (PSA) or kallikrein-related peptidase 2 (hK2) secreted by novel transgenic mice models critically influence development of prostate cancer or release of PSA or hK2 in blood
    Meeting Abstract

    Braun, K.; Ulmert, D.; von Bodman, C.; Byers, A.; Mehta, D.; Johnson, L.; Wenske, S.; Hricik, T.; Heller, G.; Scher, H.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies
    Meeting Abstract

    Mitsiades, N.; Schultz, N.; Taylor, B. S.; Hieronymus, H.; Satagopan, J.; Scardino, P. T.; Reuter, V. E.; Sander, C.; Sawyers, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prostate cancer topography and patterns of lymph node metastasis
    Meeting Abstract

    Tokuda, Y.; Kaag, M.; Gopalan, A.; Tickoo, S. K.; Guillonneau, B.; Eastham, J. A.; Scardino, P. T.; Scher, H. I.; Reuter, V. E.; Fine, S. W.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Catalytic form of human kallikrein-related peptidase 2 (hK2) promote cellular migration and invasion in vitro
    Meeting Abstract

    Wenske, S.; Hricik, T.; Benchickh, A.; Cordon-Cardo, C.; Pandolfi, P. P.; Heller, G.; Scher, H. I.; Scardino, P. T.; Carver, B.; Lilja, H.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy
    Meeting Abstract

    Dotan, Z. A.; Sathyamoorthy, K.; Bianco, F. J.; Stephenson, A. J.; Eastham, J. A.; Fearn, P.; Schoder, H.; Scher, H. I.; Scardino, P. T.; Kattan, M. W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Systems pathology for building predictive models: The androgen receptor as a prototype biomarker in prostate cancer progression and targeted therapeutic response assessment
    Meeting Abstract

    Donovan, M. J.; Scher, H.; Scardino, P.; Kotsianti, A.; Cordon-Cardo, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save